Back to Search Start Over

mdmx is a negative regulator of p53 activity in vivo.

Authors :
Finch RA
Donoviel DB
Potter D
Shi M
Fan A
Freed DD
Wang CY
Zambrowicz BP
Ramirez-Solis R
Sands AT
Zhang N
Source :
Cancer research [Cancer Res] 2002 Jun 01; Vol. 62 (11), pp. 3221-5.
Publication Year :
2002

Abstract

Regulation of p53 protein activity is required for normal embryogenesis, tumor suppression, and cellular response to DNA damage. Here we report that loss of mdmx, a p53-binding protein, results in midgestational embryo lethality, a phenotype that is completely rescued by the absence of p53. Mice homozygous for both mdmx and p53 null mutations are viable and appear developmentally normal. Fibroblasts derived from embryos with reduced mdmx expression demonstrate a decreased growth rate and increased UV-induced apoptosis compared with wild-type cells and contain elevated levels of p53 and several p53 target proteins including the proapoptotic bax protein. These observations demonstrate that mdmx functions as a critical negative regulator of p53 in vivo.

Details

Language :
English
ISSN :
0008-5472
Volume :
62
Issue :
11
Database :
MEDLINE
Journal :
Cancer research
Publication Type :
Academic Journal
Accession number :
12036937